ClinicalTrials.gov
public full text
Public Domain
Metformin Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease#640543
- Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study#398287
- Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI#801015
- Coronary Arterial Microcirculation and Metabolism#878699
- Molecular Pathways of Cardiac Remodellation in Patients With Acute and Chronic Left Ventricular Disfunction#1103947
Record · ID 208424
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive